Status:
UNKNOWN
Study of Early-stage Lung Adenocarcinoma for Early Detection and Effective Treatment Strategy
Lead Sponsor:
Samsung Medical Center
Collaborating Sponsors:
Korean Foundation for Cancer Research
Conditions:
Lung Adenocarcinoma
Eligibility:
All Genders
20+ years
Brief Summary
to determine the values of imaging and genetic biomarkers for prediction of tumor aggressiveness and prognosis in patient with early stage lung adenocarcinoma to Identify unique copy number alteration...
Eligibility Criteria
Inclusion
- A. Clinically and radiologically suspected lung adenocarcinoma
- B. Newly-diagnosed Stage I or II from the clinical work up including PET/CT
- C. Performance status of 0 to 1 on the ECOG scale
- D. Age 20 years or older
- E. Able to tolerable DECT imaging required by protocol
- F. Able to give study-specific informed consent
Exclusion
- A. Prior malignancy
- B. planning of Definitive RTx 나 neoadjuvant CCRTx
- C. Poor cardiopulmonary reserve
Key Trial Info
Start Date :
October 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2016
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT01482585
Start Date
October 1 2011
End Date
December 1 2016
Last Update
November 30 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea